Evidence map›Paper›PMID 33918190›Full record

ArticleInternational journal of molecular sciences2021

Improved CRISPR/Cas9 Tools for the Rapid Metabolic Engineering of

Tom Wilding-Steele, Quentin Ramette, Paul Jacottin, Philippe Soucaille

Open access · goldAbstract readEvaluation Study
In one paragraph

Article in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Genetic disruption of the bacterialProceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  3. Improving and Streamlining Gene Editing inJournal of fungi (Basel, Switzerland) · 2024
    Article
  4. The potential of native and engineered Clostridia for biomass biorefining.Frontiers in bioengineering and biotechnology · 2024
    Review
  5. Article
  6. Refined control of CRISPR-Cas9 gene editing inFrontiers in immunology · 2023
    Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 2 countries.

Tom Wilding-SteeleINP, TBI, INSA, UPS, Université de Toulouse, 31400 Toulouse, France.
Quentin RametteINP, TBI, INSA, UPS, Université de Toulouse, 31400 Toulouse, France.
Paul JacottinINP, TBI, INSA, UPS, Université de Toulouse, 31400 Toulouse, France.
Philippe SoucailleINP, TBI, INSA, UPS, Université de Toulouse, 31400 Toulouse, France.
Centre National de la Recherche Scientifique · FRInstitut National des Sciences Appliquées de Toulouse · FRUniversité Toulouse III - Paul Sabatier · FR

Funding

Agence Nationale de la Recherche ANR-19-COBI-0004
6 · The paper itself

Abstract

Clustered regularly interspaced short palindromic repeats (CRISPR)/Cas (CRISPR-associated proteins)9 tools have revolutionized biology-several highly efficient tools have been constructed that have resulted in the ability to quickly engineer model bacteria, for example,

Indexed as

Clostridium acetobutylicumCRISPR-Associated Protein 9CRISPR-Cas SystemsGene EditingMetabolic EngineeringCRISPR-Associated Protein 9Clostridium acetobutylicumCRISPR/Cas9genetic toolsmetabolic engineering

Identifiers

PMID33918190
PMCPMC8037352
OpenAlexW3143297909

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.